As of 2025-10-27, the EV/EBITDA ratio of Treace Medical Concepts Inc (TMCI) is -12.62. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TMCI's latest enterprise value is 480.49 mil USD. TMCI's TTM EBITDA according to its financial statements is -38.07 mil USD. Dividing these 2 quantities gives us the above TMCI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 18.6x - 23.5x | 21.6x |
| Forward P/E multiples | 22.0x - 27.7x | 24.2x |
| Fair Price | (14.02) - (14.91) | (14.55) |
| Upside | -304.1% - -317.1% | -311.8% |
| Date | EV/EBITDA |
| 2025-10-24 | -12.62 |
| 2025-10-23 | -12.49 |
| 2025-10-22 | -12.60 |
| 2025-10-21 | -12.75 |
| 2025-10-20 | -12.50 |
| 2025-10-17 | -11.91 |
| 2025-10-16 | -11.81 |
| 2025-10-15 | -11.38 |
| 2025-10-14 | -11.51 |
| 2025-10-13 | -11.18 |
| 2025-10-10 | -10.98 |
| 2025-10-09 | -11.23 |
| 2025-10-08 | -11.44 |
| 2025-10-07 | -11.18 |
| 2025-10-06 | -11.67 |
| 2025-10-03 | -11.77 |
| 2025-10-02 | -11.61 |
| 2025-10-01 | -11.71 |
| 2025-09-30 | -12.35 |
| 2025-09-29 | -12.37 |
| 2025-09-26 | -12.27 |
| 2025-09-25 | -12.31 |
| 2025-09-24 | -12.47 |
| 2025-09-23 | -12.50 |
| 2025-09-22 | -12.67 |
| 2025-09-19 | -12.65 |
| 2025-09-18 | -13.15 |
| 2025-09-17 | -12.90 |
| 2025-09-16 | -12.95 |
| 2025-09-15 | -13.20 |
| 2025-09-12 | -13.20 |
| 2025-09-11 | -13.57 |
| 2025-09-10 | -12.84 |
| 2025-09-09 | -13.50 |
| 2025-09-08 | -13.02 |
| 2025-09-05 | -13.12 |
| 2025-09-04 | -13.12 |
| 2025-09-03 | -13.25 |
| 2025-09-02 | -13.12 |
| 2025-08-29 | -13.40 |
| 2025-08-28 | -13.50 |
| 2025-08-27 | -13.53 |
| 2025-08-26 | -13.57 |
| 2025-08-25 | -13.62 |
| 2025-08-22 | -14.00 |
| 2025-08-21 | -13.27 |
| 2025-08-20 | -13.07 |
| 2025-08-19 | -13.15 |
| 2025-08-18 | -12.90 |
| 2025-08-15 | -12.65 |